SOBRsafe Announces Closing of $2 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Dermata Therapeutics Announces Closing of up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

$4.1 million upfront with up to approximately $8.3 million of potential additional gross proceeds upon the exercise in full of warrants

Skincare firm Dermata raises $4.1M to back new over-the-counter acne kit

Dermata closes a $4.1M private placement for 2M shares at $2.04, with up to $8.3M more possible from warrants, to fund acne kit launch and R&D.